New turkish survey aims to better measure prostate cancer Patients' Well-Being
NCT ID NCT07448545
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study translated and tested a Turkish version of the UCLA Prostate Cancer Index, a survey that measures how prostate cancer and its treatment affect daily life. Researchers worked with 115 Turkish-speaking men diagnosed with prostate cancer to check if the new version is reliable and accurate. The goal is to give doctors a trusted tool to understand and improve quality of life for Turkish patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
115 people
The number who actually took part.
- Started
-
Jan 2022
- Finished
-
Jan 2026
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study population consists of men aged 45 years and older who have been diagnosed with prostate cancer and are attending routine follow-up visits at a urology outpatient clinic in Türkiye.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Male participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Male patients * Diagnosis of prostate cancer Exclusion Criteria: * Severe psychiatric or mental disorders that may impair the ability to complete the questionnaires properly * Presence of congenital deformities
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Prostate cancer (diagnosis) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Lokman Hekim University, Ankara, Ankara
Ankara, 6510, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heart Disease's hidden toll: study tracks quality of life across mind, body, and spirit
- 150,000 children to be tracked from birth to old age in massive health study
- Can a website help liver cancer patients care for themselves during chemoembolization?
- A 10-Question survey could give brazilian pulmonary hypertension patients a voice in their care
- Fewer dialysis sessions: can Twice-Weekly work as well?
- Two ways to rebuild a tongue: which one leaves patients better off?